Former President Donald Trump has announced new "Most Favored Nation" drug pricing deals with nine pharmaceutical companies aimed at reducing medication costs for patients in the United States. The announcement was made on Friday, December 19, 2025.
The initiative is part of Trump"s ongoing efforts to address high drug prices and improve access to medications for American patients. Details regarding the specific companies involved in the agreements were not disclosed in the announcement.
This move follows previous reports on the challenges faced by many Americans in affording necessary medications. The "Most Favored Nation" pricing model is designed to ensure that U.S. patients pay no more for drugs than the lowest price available in other countries.
For more information on related coverage, see recent developments in politics.
Image for Trump announces "Most Favored Nation" drug pricing deals with nine companies
The announcement is part of a broader conversation about healthcare costs and access in the U.S., which has been a significant topic in political discourse.
![[Video] RFK Jr. announces restrictions on transgender procedures, calls it malpractice](/_next/image?url=%2Fapi%2Fimage%2Fthumbnails%2Fthumbnail-1766076353014-x75r89-thumbnail.jpg&w=3840&q=75)
